Abstract
The bladder is exposed to a variety of possible injuries from the time the fetus develops. Aside from congenital abnormalities, individuals may also suffer from other disorders such as cancer, trauma, infection, inflammation, iatrogenic injuries or other conditions which may lead to bladder damage or loss, requiring eventual reconstruction.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Atala A., Retik A.: Pediatric Urology — future perspectives. In: Clinical Urology. Krane R.J., Siroky M.B., Fitzpatrick J.M. (ed) J.B. Lippincott, Philadelphia., 507, 1994.
Atala A.: Tissue engineering in the urinary tract. Dialogues in Pediatric Urology., 18: 1, 1995.
Atala A., Vacanti J.P., Peters CA., Mandell J., Retik A.B., Freeman M.R.: Formation of urothelial structures in vivo from dissociated cells attached to biodegradable polymer scaffolds in vitro. J. Urol., 148: 658, 1992.
Atala A., Freeman M.R., Vacanti J.P., Shepard J., Retik A.B.: Implantation in vivo and retrieval of artificial structures consisting of rabbit and human urothelium and human bladder muscle. J. Urol., 150: 608, 1993.
Cilento B.J., Freeman M.R., Schneck F.X., Retik A.B., Atala A.: Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro. J. Urol., 152: 665, 1994.
Tobin M.S., Freeman M.R., Atala A.: Maturational response of normal human urothelial cells in culture is dependent on extracellular matrix and serum additives. Surgical Forum., 45: 786, 1994.
Freeman M.R., Yoo J.J., Raab G., Soker S., Adam R.M., Schneck F.X., Renshaw A.A., Klagsbrun M. and Atala A.: Heparin-Binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder. Journal of Clinical Investigation., 99: 1028 1997.
Prigent S.A.: The type 1 (EGFR-related) family of growth factor receptors and their ligands. Prog. Growth Factor Res., 4: 1, 1992.
Atala A.: Replacement of urologic associated mucosa. J. Urol., 156: 338, 1996.
Suji I., Ishida H., Fujieda J.: Experimental cystoplasty using preserved bladder graft. J. Urol., 85: 42, 1961.
Sutherland R.S., Baskin L.S., Hayward S.W., Cunha G.R.: Regeneration of bladder urothelium, smooth muscle, blood vessels and nerves into an acellular matrix. J.Urol., 156: 571, 1996.
Kropp B.P., Rippy M.K., Badylak S.F., Adams M.C, Keating M.A., Rink R.C, Thor K.B.: Regenerative urinary bladder augmentation using small intestinal submucosa: urodynamic and histopathologic assesment in long term canine bladder augmentation. J. Urol., 155: 2098, 1996.
Machluff M. and Atala A.: Progress in tissue engineering: Emerging concepts for tissue and organ transplantation. Graft, in press, 1998.
Wesolowski S.A., Fries CC, Karlson K.E., et al.: Porosity: primary determinant of ultimate fate of synthetic vascular grafts. Surg., 50: 91, 1961.
Mikos A.G., Sarakinos G., Lyman M.D., et al.: Prevascularization of porous biodegradable polymers. Biotechnol. Bioeng., 42: 716, 1993.
Yoo J., Satar N., Retik A.B., Atala A.: Ureteral replacement using biodegradable polymer scaffolds seeded with urothelial and smooth muscle cells. J Urol., 153:4 (suppl), 1995.
Cilento B.G., Retik A.B., Atala A.: Urethral reconstruction using a polymer scaffolds seeded with urothelial and smooth muscle cells. J. Urol., 155:5 (suppl), 1996.
Yoo J.J, Satar N., Atala A.: Bladder augmentation using biodegradable polymer scaffolds seeded with urothelial and smooth muscle cells. J. Urol., 155: 5 (supp), 1996.
Yoo J., Oberpenning F., Atala A.: Bladder augmentation using a new biomaterial composed of allogenic bladder submucosa. Urology, in press, 1998.
Oberpenning F., Meng J., Yoo J., Atala A.: Bladder Replacement with Tissue-Engineered Neo-Organs. Pediatrics., 100S: 10, 1997.
Fauza D.O., Fishman S., Mehegan K., Atala A.: Videofetoscopically assisted fetal tissue engineering: bladder augmentation. J. Ped. Surg., in press, 1998.
Fauza D.O., Fishman S., Mehegan K., Atala A.: Videofetoscopically assisted fetal tissue engineering: skin replacement. J. Ped. Surg., in press, 1998.
Yoo J. and Atala A.: A novel gene delivery system using urothelial tissue engineered neo-organs. J.Urol.,158:1066, 1997.
Atala A., Cima L.G., Kim W., Paige K.T., Vacanti J.P., Retik A.B., Vacanti CA.: Injectable alginate seeded with chondrocytes as a potential treatment for vesicoureteral reflux. J. Urol., 150: 745, 1993.
Atala A., Kim W., Paige K.T., Vacanti CA., Retik A.B.: Endoscopic treatment of vesicoureteral reflux with chondrocyte-alginate suspension. J. Urol., 152: 641, 1994.
Atala, A.: Use of autologous substances in VUR and Incontinence treatment. Dialogues in Pediatric Urology., 18:1, 1995.
Joyner B. and Atala A. Endoscopic substances for the management of vesicoureteral reflux, Urology; 50: 489,1997.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Atala, A. (1999). Creation of Bladder Tissue in Vitro and in Vivo. In: Baskin, L.S., Hayward, S.W. (eds) Advances in Bladder Research. Advances in Experimental Medicine and Biology, vol 462. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4737-2_3
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4737-2_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7147-2
Online ISBN: 978-1-4615-4737-2
eBook Packages: Springer Book Archive